Trends, patient and prescriber characteristics in gabapentinoid use in a sample of United States ambulatory care visits from 2003 to 2016

Lili Zhou, Sandipan Bhattacharjee, C. Kent Kwoh, Patrick J. Tighe, Daniel C. Malone, Marion Slack, Debbie L. Wilson, Joshua D. Brown, Wei Hsuan Lo-Ciganic

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Increasing gabapentinoid use has raised concerns of misuse and abuse in the United States (US). Little is known about the characteristics of gabapentinoid use in general clinical practice over time. This cross-sectional study used data from the National Ambulatory Medical Care Survey. We examined the trends of patient and prescriber characteristics and the diagnoses associated with US ambulatory care visits involving gabapentinoids for adult visits from 2003 to 2016. Using multivariable logistic regression, we estimated the adjusted proportion of gabapentinoid-involved visits among all visits and tested for trend significance. Among the weighted estimate of 260.1 million gabapentinoid-involved visits (aged 18–64 years: 61.8%; female: 61.9%; white: 85.5%), the adjusted annual proportion of gabapentinoid-involved visits nearly quadrupled from 2003 to 2016 (9.1 to 34.9 per 1000 visits; Ptrend < 0.0001), driven mainly by gabapentin. Nearly half had concurrent use with opioids (32.9%) or benzodiazepines (15.3%). Primary care physicians (45.8%), neurologists (8.2%), surgeons (6.2%), and psychiatrists (4.8%) prescribed two-thirds of the gabapentinoids. Most (96.6%) of the gabapentinoid visits did not have an approved indication for gabapentinoids among the first three diagnoses. Among US ambulatory care visits from 2003 to 2016, gabapentinoid use increased substantially, commonly prescribed by primary care physicians.

Original languageEnglish (US)
Article number83
JournalJournal of Clinical Medicine
Volume9
Issue number1
DOIs
StatePublished - Jan 2020
Externally publishedYes

Keywords

  • Ambulatory care visits
  • Approved indication
  • Gabapentin
  • Gabapentinoid
  • Off-label use
  • Patient and prescriber characteristics
  • Pregabalin
  • Trend

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Trends, patient and prescriber characteristics in gabapentinoid use in a sample of United States ambulatory care visits from 2003 to 2016'. Together they form a unique fingerprint.

Cite this